Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M61.1Revenue (TTM) $M21.7Net Margin (%)-343.2Altman Z-Score-72.3
Enterprise Value $M38.6EPS (TTM) $-2.7Operating Margin %-331.4Piotroski F-Score3
P/E(ttm)--Beneish M-Score-4.1Pre-tax Margin (%)-346.5Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %-55.9Quick Ratio0.8Cash flow > EarningsY
Price/Sales2.75-y EBITDA Growth Rate %-29.2Current Ratio0.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-92.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-296.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M17.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CTIC

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

CTIC is held by these investors:



CTIC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BIANCO JAMES APresident and CEO 2016-06-24Sell1,000$3.7-7.03view
BIANCO JAMES APresident and CEO 2016-05-27Sell1,000$4.5-23.56view
BIANCO JAMES APresident and CEO 2016-04-29Sell1,000$5.2-33.85view
BIANCO JAMES APresident and CEO 2016-03-28Sell1,000$4.9-29.8view
BIANCO JAMES APresident and CEO 2016-03-21Sell31,817$5.5-37.45view
Plunkett MatthewEVP, Chief Business Officer 2016-03-04Sell1,000$5.9-41.69view
BIANCO JAMES APresident and CEO 2016-02-26Sell1,000$6.3-45.4view
SINGER JACK WEVP, Chief Scientific Officer 2016-02-26Sell1,500$6.3-45.4view
BIANCO JAMES APresident and CEO 2016-02-16Sell10,000$4.2-18.1view
Plunkett MatthewEVP, Chief Business Officer 2016-02-04Sell1,000$11.5-70.09view

Press Releases about CTIC :

Quarterly/Annual Reports about CTIC:

News about CTIC:

Articles On GuruFocus.com
CTI BioPharma Receives $10 Million Milestone Payment for TRISENOX® Jun 15 2017 
CTI BioPharma Prices Underwritten Public Offering of $45 Million of Convertible Preferred Stock Jun 06 2017 
CTI BioPharma Announces Proposed Public Offering Of Convertible Preferred Stock Jun 05 2017 
CTI BioPharma Appoints David R. Parkinson, M.D., Leader in Oncology Clinical Development, to Board o Jun 05 2017 
CTI BioPharma Reports First Quarter 2017 Financial Results May 03 2017 
CTI BioPharma to Report First Quarter 2017 Financial Results on May 3, 2017 Apr 26 2017 
Servier and CTI BioPharma Expand License and Collaboration Agreement to Develop and Commercialize PI Apr 25 2017 
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against CTI BioPharma Corp. Feb 16 2016 
Monday Morning Pre-Market Insights: Celldex Therapeutics, Celladon Corp, CTI BioPharma Corp, TG Ther Jun 01 2015 
Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc., Standard Pacific Corp and Dollar G Mar 24 2014 

More From Other Websites
CTI BioPharma Receives $10 Million Milestone Payment for TRISENOX® Jun 15 2017
ETFs with exposure to CTI BioPharma Corp. : June 8, 2017 Jun 08 2017
CTI BioPharma Prices Underwritten Public Offering of $45 Million of Convertible Preferred Stock Jun 06 2017
CTI BioPharma Announces Proposed Public Offering Of Convertible Preferred Stock Jun 05 2017
CTI BioPharma Appoints David R. Parkinson, M.D., Leader in Oncology Clinical Development, to Board... Jun 05 2017
Edited Transcript of CTIC earnings conference call or presentation 3-May-17 8:30pm GMT May 09 2017
CTI BioPharma Corp. :CTIC-US: Earnings Analysis: Q1, 2017 By the Numbers : May 5, 2017 May 05 2017
CTI BioPharma reports 1Q loss May 03 2017
CTI BioPharma Reports First Quarter 2017 Financial Results May 03 2017
CTI BioPharma to Report First Quarter 2017 Financial Results on May 3, 2017 Apr 26 2017
ETFs with exposure to CTI BioPharma Corp. : April 26, 2017 Apr 26 2017
Servier and CTI BioPharma Expand License and Collaboration Agreement to Develop and Commercialize... Apr 25 2017
Edited Transcript of CTIC earnings conference call or presentation 2-Mar-17 9:30pm GMT Mar 31 2017
ETFs with exposure to CTI BioPharma Corp. : March 30, 2017 Mar 29 2017
CTI BioPharma Corp. :CTIC-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017 Mar 16 2017
CTI BioPharma to Present at the 29th Annual ROTH Conference Mar 08 2017
CTI BioPharma Reports Fourth Quarter and Full Year 2016 Financial Results Mar 02 2017
CTI BioPharma hires new CEO Mar 01 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}